Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. PINK: which is better?

Bottom line

XLV vs PINK: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight.

XLV is cheaper at 0.08% vs 0.51% — a difference of $43 a year per $10,000 invested.

Over one year, PINK returned +24.1% vs +14.5% for XLV.

Updated Nov 19, 2026

XLV vs PINK side by side

XLVPINK
TypeETFETF
Fund familySPDR (State Street)Simplify Exchange Traded
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.51%
Annual cost per $10k$8$51
10-yr cost on $10k (prospectus)$103$641
Max front loadNoneNone
12b-1 fee0.02%0%
1-yr return+14.5%+24.1%
5-yr return (annualized)+8.1%—
10-yr return (annualized)+9.8%—
Best quarter+14.5%+15.6%
Worst quarter−12.7%−9.5%
Net assets (fund)$40.6B$358.6M
Number of holdings6554
Portfolio turnover2%171%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVPINKDifference
2025+14.5%+24.1%−9.6%
2024+2.5%+8.9%−6.4%
2023+2.0%+3.8%−1.8%
2022−2.1%−4.3%+2.2%

Source: Fund prospectus bar charts

Holdings overlap

12 of XLV's top 25 holdings also appear in PINK's top 25.

Shared top holdings
HoldingXLVPINK
Eli Lilly & Co16.51%5.91%
Johnson & Johnson10.64%5.45%
AbbVie Inc7.74%4.52%
UnitedHealth Group Inc6.57%5.76%
Amgen Inc3.40%2.12%
Thermo Fisher Scientific Inc3.24%3.23%
Gilead Sciences Inc2.73%2.87%
CVS Health Corp2.30%2.01%
Vertex Pharmaceuticals Inc2.19%1.45%
Danaher Corp2.09%2.28%
Elevance Health Inc1.46%2.73%
Cardinal Health Inc0.97%1.78%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

PINK top 10

  1. Purecycle Technologies Inc — 6.89%
  2. United Therapeutics Corp — 6.86%
  3. Novo Nordisk A/s — 6.75%
  4. Eli Lilly & Company — 5.91%
  5. Unitedhealth Group Inc — 5.76%
  6. Warby Parker Inc — 5.46%
  7. Johnson & Johnson — 5.45%
  8. Jazz Pharmaceuticals Plc — 4.61%
  9. Abbvie Inc — 4.52%
  10. Biohaven Ltd — 4.32%

FAQ

What is the difference between XLV and PINK?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight. XLV is cheaper at 0.08% vs 0.51% — a difference of $43 a year per $10,000 invested.
Which is cheaper, XLV or PINK?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and PINK?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.